AAAAAA

   
Results: 1-9 |
Results: 9
ACTIVATION-DEPENDENT ALPHA-V-BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN - POTENTIAL SURROGATE FOR MONITORING ANTI-ALPHA-V-BETA-3 INTEGRIN EFFICACY
Authors: MOUSA SA BOZARTH J DEGRADO W BENNETT J
Citation: Sa. Mousa et al., ACTIVATION-DEPENDENT ALPHA-V-BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN - POTENTIAL SURROGATE FOR MONITORING ANTI-ALPHA-V-BETA-3 INTEGRIN EFFICACY, Circulation, 98(17), 1998, pp. 2753-2753
DISCOVERY OF A KEY ROLE FOR THE ALPHA-NU-BETA-3 INTEGRIN IN ACUTE ANDDELAYED VASCULAR OCCLUSION AND REOCCLUSION WITHOUT EFFECTS ON HEMOSTASIS
Authors: MOUSA SA DEGRADO W HARRISON D HOLMES D SRIVATSA SS
Citation: Sa. Mousa et al., DISCOVERY OF A KEY ROLE FOR THE ALPHA-NU-BETA-3 INTEGRIN IN ACUTE ANDDELAYED VASCULAR OCCLUSION AND REOCCLUSION WITHOUT EFFECTS ON HEMOSTASIS, Circulation, 98(17), 1998, pp. 2762-2762
ACTIVATION-DEPENDENT ALPHA-V BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN
Authors: MOUSA SA BOZARTH JM DEGRADO W BENNETT JS
Citation: Sa. Mousa et al., ACTIVATION-DEPENDENT ALPHA-V BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN, Circulation, 96(8), 1997, pp. 623-623
NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/
Authors: MOUSA SA FORSYTHE M LORELLI W BOZARTH J XUE CB WITYAK J SIELECKI TM OLSON RE DEGRADO W KAPIL R HUSSAIN M WEXLER R THOOLEN MJ REILLY TM
Citation: Sa. Mousa et al., NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/, Coronary artery disease, 7(10), 1996, pp. 767-774
DESIGN OF 2-STRANDED AND 3-STRANDED COILED-COIL PEPTIDES
Authors: BETZ S FAIRMAN R ONEIL K LEAR J DEGRADO W
Citation: S. Betz et al., DESIGN OF 2-STRANDED AND 3-STRANDED COILED-COIL PEPTIDES, Philosophical transactions-Royal Society of London. Biological sciences, 348(1323), 1995, pp. 81-88
DISULFIDE CROSS-LINKS TO PROBE THE STRUCTURE AND FLEXIBILITY OF A DESIGNED 4-HELIX BUNDLE PROTEIN
Authors: REGAN L ROCKWELL A WASSERMAN Z DEGRADO W
Citation: L. Regan et al., DISULFIDE CROSS-LINKS TO PROBE THE STRUCTURE AND FLEXIBILITY OF A DESIGNED 4-HELIX BUNDLE PROTEIN, Protein science, 3(12), 1994, pp. 2419-2427
INTRAVENOUS ANTIPLATELET EFFICACY AND SAFETY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP-728 IN ANESTHETIZED DOGS/
Authors: MOUSA SA FLINT S LORELLI W HASSELL S BOZARTH J DEGRADO W REILLY TM
Citation: Sa. Mousa et al., INTRAVENOUS ANTIPLATELET EFFICACY AND SAFETY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP-728 IN ANESTHETIZED DOGS/, Thrombosis research, 76(2), 1994, pp. 109-119
TEMPLATE-CONSTRAINED CYCLIC-PEPTIDES - DESIGN OF HIGH-AFFINITY LIGANDS FOR GPIIB IIIA/
Authors: JACKSON S DEGRADO W DWIVEDI A PARTHASARATHY A HIGLEY A KRYWKO J ROCKWELL A MARKWALDER J WELLS G WEXLER R MOUSA S HARLOW R
Citation: S. Jackson et al., TEMPLATE-CONSTRAINED CYCLIC-PEPTIDES - DESIGN OF HIGH-AFFINITY LIGANDS FOR GPIIB IIIA/, Journal of the American Chemical Society, 116(8), 1994, pp. 3220-3230
ANTIPLATELET EFFICACY AND SPECIFICITY OF DMP728, A NOVEL PLATELET GPIIB IIIA RECEPTOR ANTAGONIST/
Authors: MOUSA SA BOZARTH JM FORSYTHE MS LORELLI W THOOLEN MJ RAMACHANDRAN N JACKSON S DEGRADO W REILLY TM
Citation: Sa. Mousa et al., ANTIPLATELET EFFICACY AND SPECIFICITY OF DMP728, A NOVEL PLATELET GPIIB IIIA RECEPTOR ANTAGONIST/, Cardiology, 83(5-6), 1993, pp. 374-382
Risultati: 1-9 |